Report Detail
COVID-19 Impact on Global Antibody Drugs Market Insights, Forecast to 2026
- RnM4068283 |
- 18 June, 2020 |
- Global |
- 113 Pages |
- QYResearch |
- Pharma & Healthcare
Antibody Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Antibody Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Antibody Drugs market is segmented into
Monoclonal Antibodies
Antibody-Drug Conjugates
Polyclonal Antibodies
Segment by Application, the Antibody Drugs market is segmented into
Central Nervous System (CNS) Disorders
Cancers
Autoimmune Disorders
Cardiovascular Diseases
Regional and Country-level Analysis
The Antibody Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Antibody Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Antibody Drugs Market Share Analysis
Antibody Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Antibody Drugs business, the date to enter into the Antibody Drugs market, Antibody Drugs product introduction, recent developments, etc.
The major vendors covered:
Novartis
Amgen
Bristol-Myers Squibb
F. Hoffmann-La Roche
Johnson & Johnson
AbbVie
Eli Lilly
Pfizer
Bayer
GlaxoSmithKline
Sanofi
1 Study Coverage
- 1.1 Antibody Drugs Product Introduction
- 1.2 Market Segments
- 1.3 Key Antibody Drugs Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Antibody Drugs Market Size Growth Rate by Type
- 1.4.2 Monoclonal Antibodies
- 1.4.3 Antibody-Drug Conjugates
- 1.4.4 Polyclonal Antibodies
- 1.5 Market by Application
- 1.5.1 Global Antibody Drugs Market Size Growth Rate by Application
- 1.5.2 Central Nervous System (CNS) Disorders
- 1.5.3 Cancers
- 1.5.4 Autoimmune Disorders
- 1.5.5 Cardiovascular Diseases
- 1.6 Coronavirus Disease 2019 (Covid-19): Antibody Drugs Industry Impact
- 1.6.1 How the Covid-19 is Affecting the Antibody Drugs Industry
- 1.6.1.1 Antibody Drugs Business Impact Assessment - Covid-19
- 1.6.1.2 Supply Chain Challenges
- 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
- 1.6.2 Market Trends and Antibody Drugs Potential Opportunities in the COVID-19 Landscape
- 1.6.3 Measures / Proposal against Covid-19
- 1.6.3.1 Government Measures to Combat Covid-19 Impact
- 1.6.3.2 Proposal for Antibody Drugs Players to Combat Covid-19 Impact
- 1.6.1 How the Covid-19 is Affecting the Antibody Drugs Industry
- 1.7 Study Objectives
- 1.8 Years Considered
2 Executive Summary
- 2.1 Global Antibody Drugs Market Size Estimates and Forecasts
- 2.1.1 Global Antibody Drugs Revenue 2015-2026
- 2.1.2 Global Antibody Drugs Sales 2015-2026
- 2.2 Antibody Drugs Market Size by Region: 2020 Versus 2026
- 2.2.1 Global Antibody Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Antibody Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Antibody Drugs Competitor Landscape by Players
- 3.1 Antibody Drugs Sales by Manufacturers
- 3.1.1 Antibody Drugs Sales by Manufacturers (2015-2020)
- 3.1.2 Antibody Drugs Sales Market Share by Manufacturers (2015-2020)
- 3.2 Antibody Drugs Revenue by Manufacturers
- 3.2.1 Antibody Drugs Revenue by Manufacturers (2015-2020)
- 3.2.2 Antibody Drugs Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Antibody Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Antibody Drugs Revenue in 2019
- 3.2.5 Global Antibody Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Antibody Drugs Price by Manufacturers
- 3.4 Antibody Drugs Manufacturing Base Distribution, Product Types
- 3.4.1 Antibody Drugs Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Antibody Drugs Product Type
- 3.4.3 Date of International Manufacturers Enter into Antibody Drugs Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
- 4.1 Global Antibody Drugs Market Size by Type (2015-2020)
- 4.1.1 Global Antibody Drugs Sales by Type (2015-2020)
- 4.1.2 Global Antibody Drugs Revenue by Type (2015-2020)
- 4.1.3 Antibody Drugs Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Antibody Drugs Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Antibody Drugs Sales Forecast by Type (2021-2026)
- 4.2.2 Global Antibody Drugs Revenue Forecast by Type (2021-2026)
- 4.2.3 Antibody Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Antibody Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
- 5.1 Global Antibody Drugs Market Size by Application (2015-2020)
- 5.1.1 Global Antibody Drugs Sales by Application (2015-2020)
- 5.1.2 Global Antibody Drugs Revenue by Application (2015-2020)
- 5.1.3 Antibody Drugs Price by Application (2015-2020)
- 5.2 Antibody Drugs Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Antibody Drugs Sales Forecast by Application (2021-2026)
- 5.2.2 Global Antibody Drugs Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Antibody Drugs Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Antibody Drugs by Country
- 6.1.1 North America Antibody Drugs Sales by Country
- 6.1.2 North America Antibody Drugs Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Antibody Drugs Market Facts & Figures by Type
- 6.3 North America Antibody Drugs Market Facts & Figures by Application
7 Europe
- 7.1 Europe Antibody Drugs by Country
- 7.1.1 Europe Antibody Drugs Sales by Country
- 7.1.2 Europe Antibody Drugs Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Antibody Drugs Market Facts & Figures by Type
- 7.3 Europe Antibody Drugs Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Antibody Drugs by Region
- 8.1.1 Asia Pacific Antibody Drugs Sales by Region
- 8.1.2 Asia Pacific Antibody Drugs Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Antibody Drugs Market Facts & Figures by Type
- 8.3 Asia Pacific Antibody Drugs Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Antibody Drugs by Country
- 9.1.1 Latin America Antibody Drugs Sales by Country
- 9.1.2 Latin America Antibody Drugs Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Antibody Drugs Market Facts & Figures by Type
- 9.3 Central & South America Antibody Drugs Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Antibody Drugs by Country
- 10.1.1 Middle East and Africa Antibody Drugs Sales by Country
- 10.1.2 Middle East and Africa Antibody Drugs Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Antibody Drugs Market Facts & Figures by Type
- 10.3 Middle East and Africa Antibody Drugs Market Facts & Figures by Application
11 Company Profiles
- 11.1 Novartis
- 11.1.1 Novartis Corporation Information
- 11.1.2 Novartis Description, Business Overview and Total Revenue
- 11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Novartis Antibody Drugs Products Offered
- 11.1.5 Novartis Recent Development
- 11.2 Amgen
- 11.2.1 Amgen Corporation Information
- 11.2.2 Amgen Description, Business Overview and Total Revenue
- 11.2.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Amgen Antibody Drugs Products Offered
- 11.2.5 Amgen Recent Development
- 11.3 Bristol-Myers Squibb
- 11.3.1 Bristol-Myers Squibb Corporation Information
- 11.3.2 Bristol-Myers Squibb Description, Business Overview and Total Revenue
- 11.3.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Bristol-Myers Squibb Antibody Drugs Products Offered
- 11.3.5 Bristol-Myers Squibb Recent Development
- 11.4 F. Hoffmann-La Roche
- 11.4.1 F. Hoffmann-La Roche Corporation Information
- 11.4.2 F. Hoffmann-La Roche Description, Business Overview and Total Revenue
- 11.4.3 F. Hoffmann-La Roche Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 F. Hoffmann-La Roche Antibody Drugs Products Offered
- 11.4.5 F. Hoffmann-La Roche Recent Development
- 11.5 Johnson & Johnson
- 11.5.1 Johnson & Johnson Corporation Information
- 11.5.2 Johnson & Johnson Description, Business Overview and Total Revenue
- 11.5.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Johnson & Johnson Antibody Drugs Products Offered
- 11.5.5 Johnson & Johnson Recent Development
- 11.6 AbbVie
- 11.6.1 AbbVie Corporation Information
- 11.6.2 AbbVie Description, Business Overview and Total Revenue
- 11.6.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 AbbVie Antibody Drugs Products Offered
- 11.6.5 AbbVie Recent Development
- 11.7 Eli Lilly
- 11.7.1 Eli Lilly Corporation Information
- 11.7.2 Eli Lilly Description, Business Overview and Total Revenue
- 11.7.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Eli Lilly Antibody Drugs Products Offered
- 11.7.5 Eli Lilly Recent Development
- 11.8 Pfizer
- 11.8.1 Pfizer Corporation Information
- 11.8.2 Pfizer Description, Business Overview and Total Revenue
- 11.8.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Pfizer Antibody Drugs Products Offered
- 11.8.5 Pfizer Recent Development
- 11.9 Bayer
- 11.9.1 Bayer Corporation Information
- 11.9.2 Bayer Description, Business Overview and Total Revenue
- 11.9.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 Bayer Antibody Drugs Products Offered
- 11.9.5 Bayer Recent Development
- 11.10 GlaxoSmithKline
- 11.10.1 GlaxoSmithKline Corporation Information
- 11.10.2 GlaxoSmithKline Description, Business Overview and Total Revenue
- 11.10.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
- 11.10.4 GlaxoSmithKline Antibody Drugs Products Offered
- 11.10.5 GlaxoSmithKline Recent Development
- 11.1 Novartis
- 11.1.1 Novartis Corporation Information
- 11.1.2 Novartis Description, Business Overview and Total Revenue
- 11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Novartis Antibody Drugs Products Offered
- 11.1.5 Novartis Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Antibody Drugs Market Estimates and Projections by Region
- 12.1.1 Global Antibody Drugs Sales Forecast by Regions 2021-2026
- 12.1.2 Global Antibody Drugs Revenue Forecast by Regions 2021-2026
- 12.2 North America Antibody Drugs Market Size Forecast (2021-2026)
- 12.2.1 North America: Antibody Drugs Sales Forecast (2021-2026)
- 12.2.2 North America: Antibody Drugs Revenue Forecast (2021-2026)
- 12.2.3 North America: Antibody Drugs Market Size Forecast by Country (2021-2026)
- 12.3 Europe Antibody Drugs Market Size Forecast (2021-2026)
- 12.3.1 Europe: Antibody Drugs Sales Forecast (2021-2026)
- 12.3.2 Europe: Antibody Drugs Revenue Forecast (2021-2026)
- 12.3.3 Europe: Antibody Drugs Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Antibody Drugs Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Antibody Drugs Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Antibody Drugs Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Antibody Drugs Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Antibody Drugs Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Antibody Drugs Sales Forecast (2021-2026)
- 12.5.2 Latin America: Antibody Drugs Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Antibody Drugs Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Antibody Drugs Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Antibody Drugs Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Antibody Drugs Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Antibody Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter’s Five Forces Analysis
- 13.5 Primary Interviews with Key Antibody Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Antibody Drugs Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
Summary:
Get latest Market Research Reports on COVID-19 Impact on Global Antibody Drugs. Industry analysis & Market Report on COVID-19 Impact on Global Antibody Drugs is a syndicated market report, published as COVID-19 Impact on Global Antibody Drugs Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Antibody Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
